Complete response to therapy: why do primary central nervous system lymphoma patients not return to work?

• Published in: Journal of neuro-oncology Vol. 149; no. 1; pp. 171 - 179
• Main Authors: Wiemann, Greta, Pertz, Milena, Kowalski, Thomas, Seidel, Sabine, Schlegel, Uwe, Thoma, Patrizia
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.08.2020; Springer Nature B.V
• Subjects: Brain cancer; Brain tumors; Central nervous system; Chemotherapy; Clinical Study; Disease control; Integration; Lymphoma; Medicine; Medicine & Public Health; Methotrexate; Nervous system; Neurology; Oncology; Patients; Quality of life; Social integration; Primary central nervous system lymphoma; Neurocognition; Social integration; Quality of life; Return to work
• ISSN: 0167-594X; 1573-7373
• DOI: 10.1007/s11060-020-03587-5

Purpose Although primary central nervous system lymphomas (PCNSL) represent extremely aggressive brain tumours, high-dose methotrexate in combination with other chemotherapeutic agents has resulted in long-term disease control in a substantial fraction of patients. Advances in treatment efficacy with longer survival resulted in a focus on additional outcome measures such as quality of life (QoL) and neurocognition. Despite recent evidence of return to work as an important aspect of patients' QoL, little is known about occupational reintegration in PCNSL long-term survivors. This study aimed to detect specific characteristics of patients who successfully resumed work after complete response to therapy. Methods Patients with ongoing complete response to therapy completed a test battery capturing neurocognition, social integration, QoL and psychological burden. Of 25 patients who had been in regular employment before diagnosis only eight returned to work after treatment (32%). Results Patients who resumed work rated important aspects of their QoL and social integration as higher and suffered less from symptoms affecting QoL than patients who did not resume work. Also, the subjective confidence in their ability to work was higher in patients who resumed work, but independent predictors of return to work were not found in logistic regression analyses. Conclusion Occupational (re)integration is of clinical relevance in PCNSL patients after complete response to therapy. Due to the small size of our cohort the present results should be considered an exploratory first step. Return to work might be a crucial aspect of QoL and (re)integration into society after cure of PCNSL.